UGP2 and colon adenocarcinoma: In our study, data from the MethSurv database indicated that the UGP2 promoter region was hypermethylated in COAD tissues compared with that in normal samples (p < 0.01), likely resulting in the silencing of UGP2 expression and contributing to tumorigenesis and progression.